A quality defect was found: boric acid content 0.3% instead of the required 2.8–3.2% and a non‑compliant form of the raw material, which may lead to compounding magistral medicines with incorrect strength. Potential effects: lack of treatment efficacy, possible disease complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the 3% boric acid solution raw material for compounding magistral medicines; pharmacies should check their stock and return the defective batch in line with the withdrawal procedure. Patien...
The Chief Pharmaceutical Inspector issued a decision to withdraw the specified batch of the pharmaceutical raw material 3% boric acid solution from the market throughout the country and granted the de...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related